HIGHLIGHTS
- who: Walter Bodmer and Vita Golubovskaya from the Weatherall Institute of Molecular Medicine, Department of Oncology, University of Oxford, Oxford , DS, UK have published the paper: Cancer Immunotherapy: Where Next?, in the Journal: Cancers 2023, 2358 of /2023/
- what: In this brief perspective, the authors provide an overview of current and future directions for cancer immunotherapy, with an emphasis on monoclonal antibody-based therapies.
SUMMARY
This completely protects the cells from adaptive immune T_cell attack against intracellular targets since the recognition by T_cells depends on the presence of HLA Class1 on . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.